Gerresheimer AG (GXI) NPV

Sell:€67.85Buy:€68.20€1.40 (2.06%)

Prices delayed by at least 15 minutes
Sell:€67.85
Buy:€68.20
Change:€1.40 (2.06%)
Prices delayed by at least 15 minutes
Sell:€67.85
Buy:€68.20
Change:€1.40 (2.06%)
Prices delayed by at least 15 minutes

Company Information

About this company

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

Key people

Axel Herberg
Independent Chairman of the Supervisory Board
Dietmar Siemssen
Chairman of the Management Board, Chief Executive Officer
Francesco Grioli
Deputy Chairman of the Supervisory Board
Bernd Metzner
Chief Financial Officer, Member of the Management Board
Lukas Burkhardt
Member of the Management Board, Responsible for the Primary Packaging Glass Division
Andrea Abt
Independent Member of the Supervisory Board
Karin Louise Dorrepaal
Independent Member of the Supervisory Board
Annette G. Koehler
Independent Member of the Supervisory Board
Peter Michael Noe
Independent Member of the Supervisory Board
Udo Johannes Vetter
Independent Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Germany
  • Sector
    Basic Materials
  • Industry
    Fabricated Plastic & Rubber
  • ISIN
    DE000A0LD6E6
  • Market cap
    €2.34bn
  • Employees
    12,012
  • Shares in issue
    34.54m
  • Exchange
    XETRA
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.